The Risk of Type 2 #diabetes is More Than Halved by Weekly Injections of the New #obesity ... - Latest Tweet by IANS India

The risk of type 2 #diabetes is more than halved by weekly injections of the new #obesity drug semaglutide, which was recently approved in the #US and has been provisionally approved in England, says a new study. pic.twitter.com/LyATStRMus— IANS (@ians_india) September 12, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)